$1.29Billion– No. of Holdings #16
| Ticker | $ Bought |
|---|---|
| damora therapeutics inc | 32,016,500 |
| aktis oncology inc | 7,424,350 |
| bitgo holdings inc | 5,484,110 |
| ip strategy holdings inc | 21,843 |
| Ticker | % Inc. |
|---|---|
| navan inc | 3.76 |
| Ticker | % Reduced |
|---|---|
| omada health inc | -33.33 |
| figma inc | -1.44 |
| Ticker | $ Sold |
|---|---|
| heritage comm corp | -129,074 |
a16z Capital Management, L.L.C. has about 67.5% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 67.5 |
| Healthcare | 18.4 |
| Communication Services | 9.4 |
| Technology | 4.7 |
a16z Capital Management, L.L.C. has about 21.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 67.5 |
| LARGE-CAP | 11.7 |
| MEGA-CAP | 9.4 |
| MICRO-CAP | 5.3 |
| MID-CAP | 3.6 |
| NANO-CAP | 2.5 |
About 25.2% of the stocks held by a16z Capital Management, L.L.C. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 74.7 |
| RUSSELL 2000 | 15.8 |
| S&P 500 | 9.4 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
a16z Capital Management, L.L.C. has 16 stocks in it's portfolio. About 96% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. ERAS was the most profitable stock for a16z Capital Management, L.L.C. last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| DNA | ginkgo bioworks holdings inc | 0.05 | 108,568 | 665,522 | unchanged | 0.00 | ||
| ERAS | erasca inc | 3.59 | 2,862,500 | 46,315,200 | unchanged | 0.00 | ||
| GLTO | damora therapeutics inc | 2.48 | 1,236,160 | 32,016,500 | new | |||
| HTBK | heritage comm corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| META | meta platforms inc | 9.42 | 212,531 | 121,595,000 | unchanged | 0.00 | ||
| NAUT | nautilus biotechnology inc | 5.31 | 17,653,900 | 68,497,200 | unchanged | 0.00 | ||
| RVMD | revolution medicines inc | 6.94 | 921,099 | 89,576,900 | unchanged | 0.00 | ||
| SQ | block inc | 4.74 | 1,016,700 | 61,184,800 | unchanged | 0.00 | ||
| navan inc | 28.95 | 28,218,700 | 373,615,000 | added | 3.76 | |||
| figma inc | 26.23 | 16,011,400 | 338,481,000 | reduced | -1.44 | |||
| bioage labs inc | 4.38 | 3,233,170 | 56,548,100 | unchanged | 0.00 | |||
| maze therapeutics inc | 3.94 | 1,702,220 | 50,811,400 | unchanged | 0.00 | |||
| omada health inc | 2.25 | 2,307,280 | 29,002,600 | reduced | -33.33 | |||
| camp4 therapeutics corp | 0.73 | 2,125,340 | 9,372,740 | unchanged | 0.00 | |||
| aktis oncology inc | 0.58 | 415,000 | 7,424,350 | new | ||||
| bitgo holdings inc | 0.42 | 666,356 | 5,484,110 | new | ||||
| ip strategy holdings inc | 0.00 | 82,740 | 21,843 | new | ||||